vs

Side-by-side financial comparison of Perimeter Solutions, Inc. (PRM) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $102.8M, roughly 1.4× Perimeter Solutions, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -136.5%, a 131.2% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 19.2%). Perimeter Solutions, Inc. produced more free cash flow last quarter ($11.6M vs $2.2M). Over the past eight quarters, Perimeter Solutions, Inc.'s revenue compounded faster (31.9% CAGR vs 22.5%).

Perimeter 81 is an Israeli cloud and network security company that develops secure remote networks, based on the zero trust architecture, for organizations. Its technology replaces legacy security appliances like VPNs and firewalls.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

PRM vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.4× larger
TOI
$142.0M
$102.8M
PRM
Growing faster (revenue YoY)
TOI
TOI
+22.4% gap
TOI
41.6%
19.2%
PRM
Higher net margin
TOI
TOI
131.2% more per $
TOI
-5.3%
-136.5%
PRM
More free cash flow
PRM
PRM
$9.4M more FCF
PRM
$11.6M
$2.2M
TOI
Faster 2-yr revenue CAGR
PRM
PRM
Annualised
PRM
31.9%
22.5%
TOI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRM
PRM
TOI
TOI
Revenue
$102.8M
$142.0M
Net Profit
$-140.2M
$-7.5M
Gross Margin
45.2%
Operating Margin
-160.7%
-4.9%
Net Margin
-136.5%
-5.3%
Revenue YoY
19.2%
41.6%
Net Profit YoY
-197.3%
43.0%
EPS (diluted)
$-0.89
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRM
PRM
TOI
TOI
Q4 25
$102.8M
$142.0M
Q3 25
$315.4M
$136.6M
Q2 25
$162.6M
$119.8M
Q1 25
$72.0M
$104.4M
Q4 24
$86.2M
$100.3M
Q3 24
$288.4M
$99.9M
Q2 24
$127.3M
$98.6M
Q1 24
$59.0M
$94.7M
Net Profit
PRM
PRM
TOI
TOI
Q4 25
$-140.2M
$-7.5M
Q3 25
$-90.7M
$-16.5M
Q2 25
$-32.2M
$-17.0M
Q1 25
$56.7M
$-19.6M
Q4 24
$144.2M
$-13.2M
Q3 24
$-89.2M
$-16.1M
Q2 24
$21.6M
$-15.5M
Q1 24
$-82.6M
$-19.9M
Gross Margin
PRM
PRM
TOI
TOI
Q4 25
45.2%
Q3 25
63.1%
Q2 25
62.4%
Q1 25
39.1%
Q4 24
48.6%
Q3 24
62.8%
Q2 24
57.6%
Q1 24
35.1%
Operating Margin
PRM
PRM
TOI
TOI
Q4 25
-160.7%
-4.9%
Q3 25
-27.7%
-5.9%
Q2 25
-16.1%
-9.4%
Q1 25
-9.5%
Q4 24
71.1%
-11.9%
Q3 24
-12.2%
-13.9%
Q2 24
35.4%
-16.6%
Q1 24
-126.8%
-19.0%
Net Margin
PRM
PRM
TOI
TOI
Q4 25
-136.5%
-5.3%
Q3 25
-28.7%
-12.1%
Q2 25
-19.8%
-14.2%
Q1 25
78.7%
-18.8%
Q4 24
167.2%
-13.1%
Q3 24
-30.9%
-16.1%
Q2 24
17.0%
-15.7%
Q1 24
-139.8%
-21.0%
EPS (diluted)
PRM
PRM
TOI
TOI
Q4 25
$-0.89
$-0.04
Q3 25
$-0.62
$-0.14
Q2 25
$-0.22
$-0.15
Q1 25
$0.36
$-0.21
Q4 24
$1.00
$-0.14
Q3 24
$-0.61
$-0.18
Q2 24
$0.14
$-0.17
Q1 24
$-0.57
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRM
PRM
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$325.9M
Total DebtLower is stronger
$669.1M
Stockholders' EquityBook value
$1.1B
$-15.7M
Total Assets
$2.7B
$164.7M
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRM
PRM
TOI
TOI
Q4 25
$325.9M
Q3 25
$340.6M
Q2 25
$140.7M
Q1 25
$200.1M
Q4 24
$198.5M
Q3 24
$223.1M
Q2 24
$43.2M
$9.9M
Q1 24
$38.7M
$29.8M
Total Debt
PRM
PRM
TOI
TOI
Q4 25
$669.1M
Q3 25
$668.8M
Q2 25
$668.4M
Q1 25
$668.1M
Q4 24
$667.8M
Q3 24
$667.4M
Q2 24
$667.1M
Q1 24
$666.8M
Stockholders' Equity
PRM
PRM
TOI
TOI
Q4 25
$1.1B
$-15.7M
Q3 25
$1.1B
$-12.3M
Q2 25
$1.2B
$-9.0M
Q1 25
$1.2B
$5.1M
Q4 24
$1.2B
$3.6M
Q3 24
$1.0B
$15.5M
Q2 24
$1.1B
$29.2M
Q1 24
$1.1B
$41.3M
Total Assets
PRM
PRM
TOI
TOI
Q4 25
$2.7B
$164.7M
Q3 25
$2.6B
$163.6M
Q2 25
$2.5B
$159.8M
Q1 25
$2.4B
$164.0M
Q4 24
$2.4B
$172.7M
Q3 24
$2.5B
$179.2M
Q2 24
$2.3B
$179.6M
Q1 24
$2.3B
$204.5M
Debt / Equity
PRM
PRM
TOI
TOI
Q4 25
0.59×
Q3 25
0.60×
Q2 25
0.57×
Q1 25
0.55×
Q4 24
0.58×
Q3 24
0.67×
Q2 24
0.62×
Q1 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRM
PRM
TOI
TOI
Operating Cash FlowLast quarter
$18.6M
$3.2M
Free Cash FlowOCF − Capex
$11.6M
$2.2M
FCF MarginFCF / Revenue
11.3%
1.5%
Capex IntensityCapex / Revenue
6.8%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$208.6M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRM
PRM
TOI
TOI
Q4 25
$18.6M
$3.2M
Q3 25
$198.7M
$-12.6M
Q2 25
$-2.9M
$-10.2M
Q1 25
$23.7M
$-5.0M
Q4 24
$-6.0M
$4.2M
Q3 24
$183.0M
$819.0K
Q2 24
$8.6M
$-15.7M
Q1 24
$2.8M
$-15.9M
Free Cash Flow
PRM
PRM
TOI
TOI
Q4 25
$11.6M
$2.2M
Q3 25
$193.6M
$-13.2M
Q2 25
$-15.6M
$-11.4M
Q1 25
$18.9M
$-5.3M
Q4 24
$-12.4M
$2.4M
Q3 24
$179.1M
$417.0K
Q2 24
$5.0M
$-17.5M
Q1 24
$1.2M
$-16.5M
FCF Margin
PRM
PRM
TOI
TOI
Q4 25
11.3%
1.5%
Q3 25
61.4%
-9.7%
Q2 25
-9.6%
-9.5%
Q1 25
26.3%
-5.1%
Q4 24
-14.4%
2.4%
Q3 24
62.1%
0.4%
Q2 24
3.9%
-17.7%
Q1 24
2.1%
-17.4%
Capex Intensity
PRM
PRM
TOI
TOI
Q4 25
6.8%
0.7%
Q3 25
1.6%
0.4%
Q2 25
7.8%
1.0%
Q1 25
6.7%
0.3%
Q4 24
7.5%
1.8%
Q3 24
1.3%
0.4%
Q2 24
2.9%
1.9%
Q1 24
2.6%
0.6%
Cash Conversion
PRM
PRM
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
0.42×
Q4 24
-0.04×
Q3 24
Q2 24
0.40×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRM
PRM

Products$87.7M85%
Service And Other$14.8M14%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons